Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-849
Published Online: 2014-11-19
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yin, Xin
Zhang, Lan
Wang, Yan-Hong
Zhang, Bo-Heng
Gan, Yu-Hong
Ge, Ning-Lin
Chen, Yi
Li, Li-Xin
Ren, Zheng-Gang
License valid from 2014-11-19
Article History
Received: 27 June 2013
Accepted: 6 November 2014
First Online: 19 November 2014